(Q35089986)

English

Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Antwan G Ederveen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

H J Kloosterboer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The Journal of Steroid Biochemistry and Molecular Biology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

83

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

157-165

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone loss in relation to menopause: a prospective study during 16 years

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of new vertebral fracture in the year following a fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex steroids and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sex steroids and the construction and conservation of the adult skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progesterone as a bone-trophic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tibolone: a steroid with a tissue-specific mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor profiling and endocrine interactions of tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor null mice: what have we learned and where will they lead us?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of tamoxifen on bone metabolism and skeletal growth is different in ovariectomized and intact rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Connections and regulation of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tibolone: a compound with tissue specific inhibitory effects on sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Variation in the Efficacy of Hormone Replacement Therapy in the Prevention of Hip Fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Raloxifene preserves bone strength and bone mass in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term effects of tibolone on the genital tract in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-oestrogenic drugs and endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Raloxifene: risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The selective estrogen enzyme modulator (SEEM) in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2803%2900055-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-0760(03)00055-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

release_b2hkpeg6srchvjht3i4oditgpe

1 reference

https://api.fatcat.wiki/v0/release/b2hkpeg6srchvjht3i4oditgpe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12650712%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35089986&oldid=2047537068"